StartUp Health January 18, 2022

Maze Therapeutics brought in $190M this week; other large rounds went to Verana Health ($150M) and Medically Home ($110M).

Our team tracked more than $670M in health innovation funding reported this week, led by Maze Therapeutics, a South San Francisco, CA-based company translating genetic insights into new precision medicines. The $190M round was led by Matrix Capital Management, with participation from General Catalyst, a16z Bio+Health, Woodline Partners, Casdin Capital, City Hill Ventures, Foresite Capital, Driehaus Capital Management, Moore Strategic Ventures, Terra Magnum Capital Partners, NS Investments, and others. source>

Other recent deals included:

Verana Health, a San Francisco, CA-based digital health company that delivers drug lifecycle and medical practice insights from a real-world data network, raised $150M led by Johnson...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Investments, Pharma / Biotech, Precision Medicine, Technology, Trends
Zephyr AI Raises $111 Million in Series A Financing
Private equity pushes wave of healthcare bankruptcies
What 2024 Valley titans want (and get wrong)
Investors Put $15M Bet on SMI-Focused Startup Amae Health
Regeneron signs Mammoth gene editing deal worth $100M upfront

Share This Article